Flannigan G - Search Results

1

Comparison of scanning Kelvin probe with SEM/EPMA techniques for fingermark recovery from metallic surfaces.

Challinger SE, Baikie ID, Flannigan G, Halls S, Laing K, Daly L, Nic Daeid N. Challinger SE, et al. Among authors: flannigan g. Forensic Sci Int. 2018 Oct;291:44-52. doi: 10.1016/j.forsciint.2018.07.025. Epub 2018 Jul 30. Forensic Sci Int. 2018. PMID: 30138750

2

Surgical equipment for benign prostate surgery: the relative merits of uniploar diathermy resection, plasma kinetic resection and laser vaporisation of the prostate.

Flannigan GM. Flannigan GM. J Perioper Pract. 2012 Nov;22(11):suppl 05, 7. J Perioper Pract. 2012. PMID: 23311016 No abstract available.

3

Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention*.

Palit V, Shah T, Biyani CS, Elmasry Y, Sarkar R, Flannigan GM, Puri R. Palit V, et al. Among authors: flannigan gm. Int Urol Nephrol. 2005;37(3):507-10. doi: 10.1007/s11255-004-4709-1. Int Urol Nephrol. 2005. PMID: 16307331

4

NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.

Basu S, Brown JE, Flannigan GM, Gill JH, Loadman PM, Martin SW, Naylor B, Puri R, Scally AJ, Seargent JM, Shah T, Phillips RM. Basu S, et al. Among authors: flannigan gm. Int J Oncol. 2004 Oct;25(4):921-7. Int J Oncol. 2004. PMID: 15375541

5

Detection of (NAD(P)H:Quinone oxidoreductase-1, EC 1.6.99.2) 609C-->T and 465C-->T polymorphisms in formalin-fixed, paraffin-embedded human tumour tissue using PCR-RFLP.

Phillips RM, Basu S, Brown JE, Flannigan GM, Loadman PM, Martin SW, Naylor B, Puri R, Shah T. Phillips RM, et al. Among authors: flannigan gm. Int J Oncol. 2004 Apr;24(4):1005-10. Int J Oncol. 2004. PMID: 15010841

6

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy.

Basu S, Brown JE, Flannigan GM, Gill JH, Loadman PM, Martin SW, Naylor B, Scally AJ, Seargent JM, Shah T, Puri R, Phillips RM. Basu S, et al. Among authors: flannigan gm. Int J Cancer. 2004 May 1;109(5):703-9. doi: 10.1002/ijc.20005. Int J Cancer. 2004. PMID: 14999778 Free article.

7

Macroscopic single-layer vasectomy reversal technique.

Ganta SB, Choudry GA, Shah ZH, Flannigan GM. Ganta SB, et al. Among authors: flannigan gm. BJU Int. 2003 Oct;92(6):650. doi: 10.1046/j.1464-410x.2003.04453.x. BJU Int. 2003. PMID: 14511055 No abstract available.

8

Randomised, placebo controlled, double blind study of alfuzosin SR in patients undergoing trial without catheter following acute urinary retention.

Shah T, Palit V, Biyani S, Elmasry Y, Puri R, Flannigan GM. Shah T, et al. Among authors: flannigan gm. Eur Urol. 2002 Oct;42(4):329-32; discussion 332. doi: 10.1016/s0302-2838(02)00319-6. Eur Urol. 2002. PMID: 12361896 Clinical Trial.

9

A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9.

Choudry GA, Stewart PA, Double JA, Krul MR, Naylor B, Flannigan GM, Shah TK, Brown JE, Phillips RM. Choudry GA, et al. Among authors: flannigan gm. Br J Cancer. 2001 Oct 19;85(8):1137-46. doi: 10.1054/bjoc.2001.2056. Br J Cancer. 2001. PMID: 11710826 Free PMC article.

10

Risk factors and behaviors associated with separation anxiety in dogs.

Flannigan G, Dodman NH. Flannigan G, et al. J Am Vet Med Assoc. 2001 Aug 15;219(4):460-6. doi: 10.2460/javma.2001.219.460. J Am Vet Med Assoc. 2001. PMID: 11518171 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page